Prenatal & Newborn Genetic Testing Market cover

Prenatal & Newborn Genetic Testing Market by Technology (Diagnostics Methods [Polymerase Chain Reaction, Array-comparative Genetic Hybridization, and Fluorescence In-situ Hybridization] and Screening Techniques [Non-invasive Prenatal Tests {Verifi, Harmony, Maternit21 Plus, Panorama, Prena Test, and Bambni Test} and Maternal Serum Screening]) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: FB-2599
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 194
  • Format:
  • Pub. Date: Upcoming
  • Share:

The genetic disorders such as Down’s syndrome, cystic fibrosis, Tay-Sachs disease, phenylketonuria (PKU), and sickle cell disease are observed among the children of a family irrespective of their health conditions. Prenatal and newborn genetic tests are diagnostic tests for early detection to determine whether the baby is vulnerable to develop such conditions due to genetic disorders. The tests are used to identify the possible health condition of a baby before and after the baby is born. In other words, the tests are primarily conducted to make better healthcare decisions for the baby as these tests provide accurate information about baby’s health and of mother. These tests examine the identification of genetic disorders in infants at the time of birth along with proper early treatment so that they lead a healthy and productive life.

Prenatal & Newborn Genetic Testing Market summary

As per the report published by the World Health Organization (WHO) in 2016, around 8 million infants around the globe were diagnosed with inborn genetic defects. Additionally, as per the Centers for Disease Control and Prevention (CDC), every one in 33 babies suffer from birth defects in the US. The Down syndrome happens to one in 691 infants in the US, according to CDC’s data of year 2017. 

Market Trends, Drivers, Restraints, and Opportunities

  • High disease prevalence along extensive research and development activities in the field with new drug discovery is driving the market growth.
  • Heavy investments in the diagnosis and treatment of diseases by several major market players are propelling the market expansion.
  • Increasing awareness of the population related to the diseases and benefits regarding early diagnosis are expected to boost the market growth during the forecast period.
  • Rising demand for detecting genetic abnormalities as well as sex determination of fetus before eight to 11 months gestation are pushing towards positive growth of the market.
  • Ethical concerns about the testing of new-born and prenatal is proved to be a major challenge that can restrain the market expansion in the coming years. 
  • Increasing incidence of false or inaccurate results in the testing is hampering the market growth.
  • High prevalence, increased awareness, government initiatives, and R&D activities are offering huge opportunities for the market growth in the coming years.

Scope of the Report

The report on the global prenatal & newborn genetic testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Prenatal & Newborn Genetic Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Technology (Diagnostics Methods [Polymerase Chain Reaction, Array-comparative Genetic Hybridization, and Fluorescence In-situ Hybridization] and Screening Techniques [Non-invasive Prenatal Tests {Verifi, Harmony, Maternit21 Plus, Panorama, Prena Test, and Bambni Test} and Maternal Serum Screening])

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Bio-Rad Laboratories Inc.; Agilent Technologies Inc.; Illumina, Inc.; and Natera Inc.

Market Segment Insights

Diagnostics segment is expected to grow at a rapid pace

Based on technology, the global prenatal & newborn genetic testing market is bifurcated into diagnostics methods and screening techniques. The diagnostics segment is further classified into array-comparative genetic hybridization, polymerase chain reaction, and fluorescence in-situ hybridization. The screening techniques segment is further bifurcated into non-invasive prenatal tests and maternal serum screening. The non-invasive prenatal tests is sub-segregated into maternit21 plus, verifi, harmony, prena test, panorama, and bambni test.

Prenatal & Newborn Genetic Testing Market technology

The diagnostics segment is expected to grow at a rapid pace during the forecast period owing to the high prevalence of diseases and increasing government initiatives in the field. Moreover, heavy investments in the R&D activities by the major players for enhancing diagnostic techniques is propelling the segment growth substantially. The screening techniques segment, however, is expected to grow at considerable CAGR during the forecast period due to increased awareness about the disease and increased demand for screening.

North America is anticipated to constitute a key market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the projected period owing to high population and high quality research in the region. Furthermore, high investment by government and non-government organizations for R&D activities as well as strong pipeline of new products are boosting the market expansion of the region.

Prenatal & Newborn Genetic Testing Market region

On the other hand, the Asia Pacific market is anticipated to expand at a significant growth rate in the near future owing to the high number of cases in the region and growing awareness about the importance of early diagnostics among a large number of the population in the region. Government policies and developing healthcare facilities present key factors for development of the regional market.

Segments

Segments Covered in the Report

The global prenatal & newborn genetic testing market has been segmented on the basis of

Technology

  • Diagnostics Methods
    • Polymerase Chain Reaction
    • Array-comparative Genetic Hybridization
    • Fluorescence In-situ Hybridization
  • Screening Techniques
    • Non-invasive Prenatal Tests
      • Verifi
      • Harmony
      • Maternit21 Plus
      • Panoramal
      • Prena Test
      • Bambni Test
    • Maternal Serum Screening

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Bio-Rad Laboratories Inc.
  • Agilent Technologies Inc.
  • Illumina, Inc.
  • Natera Inc.

Competitive Landscape

The key players competing in the global prenatal & newborn genetic testing market are Bio-Rad Laboratories Inc.; Agilent Technologies Inc.; Illumina, Inc.; and Natera Inc. Some of these players are actively engaged in several market development strategies such as new product launching, entering into collaboration and partnership, and production capacity expansion to enhance their market share and expand their geographical reach.

Prenatal & Newborn Genetic Testing Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Prenatal & Newborn Genetic Testing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Prenatal & Newborn Genetic Testing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Prenatal & Newborn Genetic Testing Market - Supply Chain
  4.5. Global Prenatal & Newborn Genetic Testing Market Forecast
     4.5.1. Prenatal & Newborn Genetic Testing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Prenatal & Newborn Genetic Testing Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Prenatal & Newborn Genetic Testing Market Absolute $ Opportunity
5. Global Prenatal & Newborn Genetic Testing Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Prenatal & Newborn Genetic Testing Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Prenatal & Newborn Genetic Testing Demand Share Forecast, 2019-2026
6. North America Prenatal & Newborn Genetic Testing Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Prenatal & Newborn Genetic Testing Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Prenatal & Newborn Genetic Testing Demand Share Forecast, 2019-2026
7. Latin America Prenatal & Newborn Genetic Testing Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Prenatal & Newborn Genetic Testing Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Prenatal & Newborn Genetic Testing Demand Share Forecast, 2019-2026
8. Europe Prenatal & Newborn Genetic Testing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Prenatal & Newborn Genetic Testing Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Prenatal & Newborn Genetic Testing Demand Share Forecast, 2019-2026
9. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Prenatal & Newborn Genetic Testing Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Prenatal & Newborn Genetic Testing Demand Share Forecast, 2019-2026
10. Middle East & Africa Prenatal & Newborn Genetic Testing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Prenatal & Newborn Genetic Testing Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Prenatal & Newborn Genetic Testing Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Prenatal & Newborn Genetic Testing Market: Market Share Analysis
  11.2. Prenatal & Newborn Genetic Testing Distributors and Customers
  11.3. Prenatal & Newborn Genetic Testing Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Bio-Rad Laboratories Inc.
     11.4.2. Agilent Technologies Inc.
     11.4.3. Illumina, Inc.
     11.4.4. Natera Inc.

Segments Covered in the Report

The global prenatal & newborn genetic testing market has been segmented on the basis of

Technology

  • Diagnostics Methods
    • Polymerase Chain Reaction
    • Array-comparative Genetic Hybridization
    • Fluorescence In-situ Hybridization
  • Screening Techniques
    • Non-invasive Prenatal Tests
      • Verifi
      • Harmony
      • Maternit21 Plus
      • Panoramal
      • Prena Test
      • Bambni Test
    • Maternal Serum Screening

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Bio-Rad Laboratories Inc.
  • Agilent Technologies Inc.
  • Illumina, Inc.
  • Natera Inc.

The key players competing in the global prenatal & newborn genetic testing market are Bio-Rad Laboratories Inc.; Agilent Technologies Inc.; Illumina, Inc.; and Natera Inc. Some of these players are actively engaged in several market development strategies such as new product launching, entering into collaboration and partnership, and production capacity expansion to enhance their market share and expand their geographical reach.

Prenatal & Newborn Genetic Testing Market keyplayers

Buy Report